Effects of macrophage colony-stimulating factor (M-CSF) on anti-fungal activity of mononuclear phagocytes against Trichosporon asahii.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 1905513)

Published in Clin Exp Immunol on February 01, 2000

Authors

E Sasaki1, T Tashiro, M Kuroki, M Seki, Y Miyazaki, S Maesaki, K Tomono, J Kadota, S Kohno

Author Affiliations

1: Second Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki, Japan.

Articles cited by this

Trichosporon beigelii, an emerging pathogen resistant to amphotericin B. J Clin Microbiol (1990) 2.99

Contributions to a revision of the genus Trichosporon. Antonie Van Leeuwenhoek (1992) 2.14

Macrophage growth factor CSF-1 stimulates human monocyte production of interferon, tumor necrosis factor, and colony stimulating activity. J Immunol (1986) 2.04

Effects of tumour necrosis factor alpha and interleukin-1 alpha and beta on human neutrophil migration, respiratory burst and degranulation. Int Arch Allergy Appl Immunol (1988) 1.78

Tumor necrosis factor alpha has a protective role in a murine model of systemic candidiasis. Infect Immun (1994) 1.37

Assignment and serotyping of Trichosporon species: the causative agents of summer-type hypersensitivity pneumonitis. J Med Vet Mycol (1997) 1.34

Interferon-gamma and tumor necrosis factor-alpha protect mice from invasive aspergillosis. J Infect Dis (1995) 1.22

Effects of macrophage colony-stimulating factor on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. J Infect Dis (1995) 1.22

Disseminated Trichosporon beigelii infection in patients with malignant diseases: immunohistochemical study and review. Eur J Clin Microbiol Infect Dis (1994) 1.14

Trichosporon beigelii pneumonia in patients with hematologic malignancies. Chest (1995) 1.14

Comparative efficacies of amphotericin B, triazoles, and combination of both as experimental therapy for murine trichosporonosis. Antimicrob Agents Chemother (1994) 1.13

The role of phagocytic cells in resistance to disseminated candidiasis in granulocytopenic mice. J Infect Dis (1994) 1.00

Phase I trial of recombinant human macrophage colony-stimulating factor in patients with invasive fungal infections. Blood (1991) 0.94

Long-term follow-up of patients with invasive fungal disease who received adjunctive therapy with recombinant human macrophage colony-stimulating factor. Blood (1993) 0.93

Biological activities and clinical application of M-CSF. Int J Hematol (1998) 0.93

Efficacy of amphotericin B and azoles alone and in combination against disseminated trichosporonosis in neutropenic mice. Chemotherapy (1998) 0.93

The effects of colony stimulating factors on human monocyte cell function. Int J Immunopharmacol (1995) 0.89

Macrophage colony-stimulating factor induces interleukin-8 production in human monocytes. Exp Hematol (1996) 0.88

Effects of granulocyte and granulocyte-macrophage colony-stimulating factors in a neutropenic murine model of trichosporonosis. Infect Immun (1997) 0.86

Response of human polymorphonuclear leukocytes and monocytes to Trichosporon beigelii: host defense against an emerging opportunistic pathogen. J Infect Dis (1994) 0.85

Effect of in vivo macrophage colony-stimulating factor on fungistasis of bronchoalveolar and peritoneal macrophages against Cryptococcus neoformans. Antimicrob Agents Chemother (1994) 0.85

Killing of Histoplasma capsulatum by macrophage colony stimulating factor-treated human monocyte-derived macrophages: role for reactive oxygen intermediates. J Med Microbiol (1995) 0.83

Human urinary macrophage colony-stimulating factor reduces the incidence and duration of febrile neutropenia and shortens the period required to finish three courses of intensive consolidation therapy in acute myeloid leukemia: a double-blind controlled study. J Clin Oncol (1997) 0.80

Effect of macrophage colony-stimulating factor (M-CSF) on mouse immune responses in vivo. Immunopharmacol Immunotoxicol (1998) 0.80

GM-CSF-modulated phagocytosis of Trichosporon beigelii by human neutrophils. J Med Microbiol (1997) 0.80

Antifungal activity of recombinant human macrophage colony-stimulating factor in models of acute and chronic candidiasis in the rat. J Infect Dis (1994) 0.79

Articles by these authors

Identification of CRE1 as a cytokinin receptor from Arabidopsis. Nature (2001) 4.77

Endoscopic submucosal dissection for early gastric cancer: a large-scale feasibility study. Gut (2008) 4.07

Regulation of drought tolerance by gene manipulation of 9-cis-epoxycarotenoid dioxygenase, a key enzyme in abscisic acid biosynthesis in Arabidopsis. Plant J (2001) 3.92

Relationship between rifampin MICs for and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan. Antimicrob Agents Chemother (1996) 3.82

Array-based genomic resequencing of human leukemia. Oncogene (2010) 3.77

Plasma (1-->3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet (1995) 3.64

Autoregulatory frameshifting in decoding mammalian ornithine decarboxylase antizyme. Cell (1995) 3.64

Rapid detection and evaluation of clinical characteristics of emerging multiple-drug-resistant gram-negative rods carrying the metallo-beta-lactamase gene blaIMP. Antimicrob Agents Chemother (1998) 3.57

Relationship between antimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis. J Antimicrob Chemother (1998) 3.41

Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J Biol Chem (1993) 2.81

Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study. Diabetologia (2003) 2.80

International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections. Clin Infect Dis (1997) 2.78

A transmembrane hybrid-type histidine kinase in Arabidopsis functions as an osmosensor. Plant Cell (1999) 2.62

The mouse gene for vascular endothelial growth factor. Genomic structure, definition of the transcriptional unit, and characterization of transcriptional and post-transcriptional regulatory sequences. J Biol Chem (1996) 2.58

Hepatitis C virus infection in spouses of patients with type C chronic liver disease. Ann Intern Med (1994) 2.38

Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virol (1990) 2.30

Nested polymerase chain reaction for detection of Mycobacterium tuberculosis in clinical samples. J Clin Microbiol (1993) 2.27

Redefined nomenclature for members of the carcinoembryonic antigen family. Exp Cell Res (1999) 2.25

Fulminating lactose-positive Vibrio septicemia. Acta Pathol Jpn (1978) 2.20

Application of a reverse transcription-PCR for identification and differentiation of Aichi virus, a new member of the Picornavirus family associated with gastroenteritis in humans. J Clin Microbiol (2000) 2.19

An Arabidopsis gene family encoding DRE/CRT binding proteins involved in low-temperature-responsive gene expression. Biochem Biophys Res Commun (1998) 2.18

Investigation of the mechanism of alcohol-induced bronchial asthma. J Allergy Clin Immunol (1996) 2.16

Abscopal regression of hepatocellular carcinoma after radiotherapy for bone metastasis. Gut (1998) 2.11

LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers. Gastroenterology (2001) 2.02

Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology (2001) 1.91

A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Am Rev Respir Dis (1993) 1.91

Molecular cloning of a novel melanocortin receptor. J Biol Chem (1993) 1.89

Effect of forest bathing on physiological and psychological responses in young Japanese male subjects. Public Health (2011) 1.88

Advanced glycation end products increase retinal vascular endothelial growth factor expression. J Clin Invest (1998) 1.85

Age-related changes in the subsets and functions of human T lymphocytes. J Immunol (1978) 1.82

Clinical evaluation of 61 patients with pulmonary aspergilloma. Intern Med (2000) 1.82

Possible association of BLM in decreasing DNA double strand breaks during DNA replication. EMBO J (2000) 1.78

Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization. Invest Ophthalmol Vis Sci (1998) 1.77

Fluconazole resistance associated with drug efflux and increased transcription of a drug transporter gene, PDH1, in Candida glabrata. Antimicrob Agents Chemother (1998) 1.76

Visiting a forest, but not a city, increases human natural killer activity and expression of anti-cancer proteins. Int J Immunopathol Pharmacol (2008) 1.76

Prospective comparative study of ofloxacin or ethambutol for the treatment of pulmonary tuberculosis. Chest (1992) 1.75

Organization and expression of two Arabidopsis DREB2 genes encoding DRE-binding proteins involved in dehydration- and high-salinity-responsive gene expression. Plant Mol Biol (2000) 1.73

Penetration of macrolides into human polymorphonuclear leucocytes. J Antimicrob Chemother (1989) 1.71

In vitro and in vivo activities of sparfloxacin against Mycoplasma pneumoniae. Antimicrob Agents Chemother (1994) 1.65

Plasma (1-->3)-beta-D-glucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis. J Clin Microbiol (1995) 1.63

Peroxisome proliferator-activated receptor gamma induces growth arrest and differentiation markers of human colon cancer cells. Jpn J Cancer Res (1999) 1.63

Long-term inhibition of NO synthesis promotes atherosclerosis in the hypercholesterolemic rabbit thoracic aorta. PGH2 does not contribute to impaired endothelium-dependent relaxation. Arterioscler Thromb (1994) 1.63

Multiple hepatic peribiliary cysts discovered incidentally at a medical examination. J Gastroenterol Hepatol (2001) 1.62

Relationship between C-reactive protein and visceral adipose tissue in healthy Japanese subjects. Diabetes Obes Metab (2004) 1.62

A forest bathing trip increases human natural killer activity and expression of anti-cancer proteins in female subjects. J Biol Regul Homeost Agents (2008) 1.61

Short report: possible Cryptosporidium muris infection in humans. Am J Trop Med Hyg (2000) 1.59

Analyses of ornithine decarboxylase antizyme mRNA with a cDNA cloned from rat liver. J Biochem (1990) 1.57

Role of coagulase in a murine model of hematogenous pulmonary infection induced by intravenous injection of Staphylococcus aureus enmeshed in agar beads. Infect Immun (1997) 1.57

Complications after cyst excision with hepaticoenterostomy for choledochal cysts and their surgical management in children versus adults. J Pediatr Surg (1997) 1.56

Bromocriptine: a novel approach to the treatment of type 2 diabetes. Diabetes Care (2000) 1.55

Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men. Mol Cell (1999) 1.54

Rhodamine 6G efflux for the detection of CDR1-overexpressing azole-resistant Candida albicans strains. J Antimicrob Chemother (1999) 1.54

The antimicrobial activity of ciprofloxacin against Legionella species and the treatment of experimental Legionella pneumonia in guinea pigs. J Antimicrob Chemother (1986) 1.51

Clinicopathological factors associated with clinical outcomes of endoscopic submucosal dissection for colorectal epithelial neoplasms. Endoscopy (2009) 1.51

Effect of intravenous omega-6 and omega-3 fat emulsions on nitrogen retention and protein kinetics in burned rats. Nutrition (1999) 1.50

The effects of exercise in forest and urban environments on sympathetic nervous activity of normal young adults. J Int Med Res (2006) 1.49

Profiles of cytokines produced by CD4-positive T lymphocytes stimulated by anti-CD3 antibody in patients with chronic hepatitis C. J Gastroenterol (1998) 1.49

Requirement of B7 costimulation for Th1-mediated inflammatory bone resorption in experimental periodontal disease. J Immunol (2000) 1.49

Hepatic artery pseudoaneurysms in a patient treated for miliary tuberculosis. Intern Med (2000) 1.48

Identification and characterization of gibberellin-insensitive mutants selected from among dwarf mutants of rice. Theor Appl Genet (1994) 1.48

Rapid prediction of rifampin susceptibility of Mycobacterium tuberculosis. Am J Respir Crit Care Med (1997) 1.47

Aetiology of maxillofacial fracture. Br J Oral Maxillofac Surg (1994) 1.47

A unique case of t(15;17) acute promyelocytic leukaemia (M3) developing into acute myeloblastic leukaemia (M1) with t(7;21) at relapse. Br J Haematol (1993) 1.46

Difference in direct charge-parity violation between charged and neutral B meson decays. Nature (2008) 1.46

Differential regulation of human RecQ family helicases in cell transformation and cell cycle. Oncogene (2000) 1.46

Regulation of vascular endothelial growth factor expression by insulin-like growth factor I. Diabetes (1997) 1.45

Intraoperative identification of canine hepatocellular carcinoma with indocyanine green fluorescent imaging. J Small Anim Pract (2013) 1.45

Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections. Eur J Immunol (1995) 1.45

Pranlukast, a cysteinyl leukotriene receptor 1 antagonist, attenuates allergen-specific tumour necrosis factor alpha production and nuclear factor kappa B nuclear translocation in peripheral blood monocytes from atopic asthmatics. Clin Exp Allergy (2003) 1.44

Acquired platinum resistance enhances tumour angiogenesis through angiotensin II type 1 receptor in bladder cancer. Br J Cancer (2011) 1.44

Elevation of sister chromatid exchange in Saccharomyces cerevisiae sgs1 disruptants and the relevance of the disruptants as a system to evaluate mutations in Bloom's syndrome gene. Mutat Res (2000) 1.44

Re-analysis of clinical features of 89 patients with autoimmune hepatitis using the revised scoring system proposed by the International Autoimmune Hepatitis Group. Intern Med (2000) 1.43

Low prevalence of Helicobacter pylori in individuals with HTLV-I infection. Eur J Gastroenterol Hepatol (1999) 1.43

Pulmonary mycobacteriosis caused by rifampicin-resistant Mycobacterium szulgai. Intern Med (2000) 1.43

Maxillofacial fractures in children. J Craniomaxillofac Surg (1993) 1.43

Crescentic glomerulonephritis with positive antineutrophil cytoplasmic autoantibody specific for myeloperoxidase associated with autoimmune hemolytic anemia and thrombocytopenic purpura. Intern Med (2000) 1.42

Distribution of mast-cell precursors in hematopoeitic and lymphopoietic tissues of mice. J Exp Med (1979) 1.41

Autoimmune reactivity of sera to hepatocyte plasma membrane in type 1 autoimmune hepatitis. J Gastroenterol (2000) 1.41

Congenital anomalies of the kidney and urinary tract--role of the loss of function mutation in the pluripotent angiotensin type 2 receptor gene. J Urol (2001) 1.41

STAT3 mediates the survival signal in oncogenic ras-transfected intestinal epithelial cells. Int J Cancer (1998) 1.41

Salinomycin, a new polyether antibiotic. J Antibiot (Tokyo) (1974) 1.40

Functional and physical interactions between AML1 proteins and an ETS protein, MEF: implications for the pathogenesis of t(8;21)-positive leukemias. Mol Cell Biol (1999) 1.40

Production of anti-cardiolipin antibody in AKR/J mice with streptozocin-induced insulitis and diabetes. Diabetes Res Clin Pract (1993) 1.40